search
Back to results

The Effects of Web-Based Training for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life

Primary Purpose

COVID-19

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
intervention group
Sponsored by
Eskisehir Osmangazi University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for COVID-19 focused on measuring web based consulting, Medication Compliance, symptom management, covid-19, life quality

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Over the age of 18,
  • Does not have a communication problem that prevents participation in research or education, such as inability to understand / speak Turkish,
  • Being literate,
  • Residing in Zonguldak province, applying to hospitals in the province and diagnosed with Covid-19 according to PCR (Polymerase Chain Reaction) test and Thorax CT (Thorax computed tomography) results by the radiation teams and deemed appropriate for home follow-up by the Zonguldak Public Health Directorate,
  • Having active Internet access and actively using a computer / tablet or smartphone,
  • Patients who agree to participate in the study

Exclusion Criteria:

  • No internet connection at home or on the phone,
  • Do not know how to use internet and computers,
  • Having a communication problem that prevents participation in research or education, such as inability to understand / speak Turkish, Patients who were previously diagnosed with Covid-19 and treated at home or in hospital,
  • With severe insufficiency (Heart failure, Kidney failure, Immune system failure)
  • Illiterate individuals will not be included in the study.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    web based training

    standard care

    Arm Description

    Patients on the first day; Patient Information Form (1st and 2nd part), Memorial Symptom Assessment Scale, Covid-19 Symptom Assessment Inventory, Morisky Compliance Scale, World Health Organization Quality of Life Scale Short Form Turkish Version, E-Health literacy scale on website or mobile devices Google via the form or by sending a phone link. Morisky Compliance Scale will be applied on the 7th day by sending a link to the website or mobile devices via google form. Patients in the intervention group will be asked to fill out the Covid-19 Symptom Assessment Inventory on the website when they experience changes in their symptoms. Patients in the intervention group will be provided with web-based training and telephone (SMS) reminder service for 4 weeks. All questionnaires and web site evaluation form will be filled in the pre-test after 4 weeks.

    The scales applied to the intervention group on the first day, by sending the E-Health literacy scale form or phone link via Google on mobile devices. The symptoms of the patients in the control group will be evaluated at the end of the 1st day, 7th day, 14th day and 4th day. No intervention was planned for the patients in the control group during the follow-up. In the standard practice protocol, after patients are informed for follow-up and treatment at home, they are called by the Ministry of Health and family physicians for symptom follow-up. The standard hospital protocol does not include a scheduled training program, telephone monitoring, or web-based training. After collecting the data in the intervention group, the website will be opened to the use of the control group.

    Outcomes

    Primary Outcome Measures

    Pre-intervention measurements
    The Covid-19 symptom assessment inventory prepared by scanning the literature will be used to monitor the symptoms. The high score obtained from the inventory indicates the need for disease management.
    Pre-intervention measurements
    Morisky drug compliance scale to measure drug compliance: is a self-report scale consisting of four questions. The questions are answered as "yes (1 point) and no (0 point). Increasing the score obtained from the scale indicates that drug compliance is low.
    Pre-intervention measurements
    The Turkish version of the World Health Organization Quality of Life Inventory Short Form will be used to measure the quality of life. The scale is a Likert type form consisting of 27 questions. Higher total scores obtained from the scale indicate a good quality of life.

    Secondary Outcome Measures

    Post-intervention measurements
    The Covid-19 symptom assessment inventory prepared by scanning the literature will be used to monitor symptoms. The high score obtained from the inventory indicates that the need for disease management continues.
    Post-intervention measurements
    Morisky drug compliance scale to measure drug compliance: is a self-report scale consisting of four questions. The questions are answered as "yes (1 point) and no (0 point). Increasing the score obtained from the scale indicates that drug compliance is low.
    Post-intervention measurements
    The Turkish version of the World Health Organization Quality of Life Inventory Short Form will be used to measure the quality of life. The scale is a Likert type form consisting of 27 questions. Higher total scores obtained from the scale indicate a good quality of life.

    Full Information

    First Posted
    March 25, 2021
    Last Updated
    November 9, 2021
    Sponsor
    Eskisehir Osmangazi University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04824469
    Brief Title
    The Effects of Web-Based Training for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life
    Official Title
    The Effects of Web-Based Training and Telephone Follow-up Developed for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2021
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    December 15, 2021 (Anticipated)
    Primary Completion Date
    May 2022 (Anticipated)
    Study Completion Date
    December 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Eskisehir Osmangazi University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    2019 coronavirus disease (Covid-19) is a virus that emerged in Wuhan, China in late 2019, spread all over the world in a short time and causes severe acute respiratory syndrome and pneumonia. The World Health Organization classified the COVID-19 outbreak as an "international public health emergency" on January 30 and declared a global epidemic (pandemic) on March 11, 2020, due to the rapid spread of the virus all over the world. speed in the number of cases and deaths. Covidien-19 first cases were reported in Turkey on 10 March 2020 and the number of cases has risen steadily. The total number of COVID-19 cases worldwide on 31.01.2021; It was reported to be 101,917,147 and the total number of deaths was 2,205,515 (https://covid19.who.int/). Considering that the number of cases is constantly increasing, it is obvious that hospitals will not meet the entire epidemic burden. During this period, home care has emerged as an alternative way to effectively alleviate the epidemic burden. Home healthcare during the COVID-19 pandemic; Four roles have stood out: home diagnosis, follow-up, treatment, and care. Protective measures for home isolation of Covid-19 patients are the current method used to prevent the spread of cases. Possible or definite cases that do not have an indication for hospitalization, have a mild clinic and do not accompany severe chronic disease that may lead to a severe course of covid-19 are followed at home until their symptoms improve. In addition, patients who are hospitalized and meet discharge criteria can complete their recovery processes at home. Isolation is terminated on the 14th day at the earliest following the improvement of symptoms in patients who are followed at home. Reducing the contact of people, isolating certain and suspicious cases and effective use of personal protective equipment play an important role in combating the epidemic. It is thought that the training that COVID-19 cases to be followed up and treated at home will be effective in drug compliance, symptom management and quality of life will be effective in the management of the disease. 1251 / 5000 Çeviri sonuçları The universe of the research will be composed of people who apply to Zonguldak Atatürk State Hospital Emergency Service and Covid-19 Polyclinics. . The sample of the study, who accepted to participate in the study, was diagnosed with Covid-19 with U07.3 ICD code according to the results of PCR (Polymerase Chain Reaction) test and Thorax CT (Thorax CT), and was recommended to be followed up and treated at home by the Zonguldak Public Health Department It is planned to create individuals who meet the criteria.
    Detailed Description
    G power analysis program was used to determine the sample size. The research will be conducted in two groups, an intervention and a control group. With professional support in calculating the sample size of the study, the sample size calculated at a 5% margin of error and a 95% confidence interval was found to be 128. However, against the possibility of sample losses during the follow-up process, the individual diagnosed with Covid-19 will be added to the number of samples by adding 20% (13 participants will be added for each group. 77 interventions in total, 77 controls) will be included in the study. Participants who meet the inclusion criteria and agree to participate in the study will be randomly assigned to the intervention and control groups. DATA COLLECTION TOOLS Patient information form Memorial Symptom Rating Scale Covid-19 Symptom Assessment Inventory Morisky Adaptation Scale (Muö) World Health Organization Quality of Life Inventory Short Form Turkish Version E-Health literacy scale Opinion Form Regarding the Web Based Training Program DISCERN Guide (Expert Opinions) Website Content Evaluation Form (Expert Opinions)

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    COVID-19
    Keywords
    web based consulting, Medication Compliance, symptom management, covid-19, life quality

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    randomized controlled experimental study
    Masking
    ParticipantOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    128 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    web based training
    Arm Type
    Experimental
    Arm Description
    Patients on the first day; Patient Information Form (1st and 2nd part), Memorial Symptom Assessment Scale, Covid-19 Symptom Assessment Inventory, Morisky Compliance Scale, World Health Organization Quality of Life Scale Short Form Turkish Version, E-Health literacy scale on website or mobile devices Google via the form or by sending a phone link. Morisky Compliance Scale will be applied on the 7th day by sending a link to the website or mobile devices via google form. Patients in the intervention group will be asked to fill out the Covid-19 Symptom Assessment Inventory on the website when they experience changes in their symptoms. Patients in the intervention group will be provided with web-based training and telephone (SMS) reminder service for 4 weeks. All questionnaires and web site evaluation form will be filled in the pre-test after 4 weeks.
    Arm Title
    standard care
    Arm Type
    No Intervention
    Arm Description
    The scales applied to the intervention group on the first day, by sending the E-Health literacy scale form or phone link via Google on mobile devices. The symptoms of the patients in the control group will be evaluated at the end of the 1st day, 7th day, 14th day and 4th day. No intervention was planned for the patients in the control group during the follow-up. In the standard practice protocol, after patients are informed for follow-up and treatment at home, they are called by the Ministry of Health and family physicians for symptom follow-up. The standard hospital protocol does not include a scheduled training program, telephone monitoring, or web-based training. After collecting the data in the intervention group, the website will be opened to the use of the control group.
    Intervention Type
    Other
    Intervention Name(s)
    intervention group
    Intervention Description
    web based training: By establishing a website, training on drug use, symptom management and quality of life will be provided.
    Primary Outcome Measure Information:
    Title
    Pre-intervention measurements
    Description
    The Covid-19 symptom assessment inventory prepared by scanning the literature will be used to monitor the symptoms. The high score obtained from the inventory indicates the need for disease management.
    Time Frame
    first day
    Title
    Pre-intervention measurements
    Description
    Morisky drug compliance scale to measure drug compliance: is a self-report scale consisting of four questions. The questions are answered as "yes (1 point) and no (0 point). Increasing the score obtained from the scale indicates that drug compliance is low.
    Time Frame
    first day
    Title
    Pre-intervention measurements
    Description
    The Turkish version of the World Health Organization Quality of Life Inventory Short Form will be used to measure the quality of life. The scale is a Likert type form consisting of 27 questions. Higher total scores obtained from the scale indicate a good quality of life.
    Time Frame
    first day
    Secondary Outcome Measure Information:
    Title
    Post-intervention measurements
    Description
    The Covid-19 symptom assessment inventory prepared by scanning the literature will be used to monitor symptoms. The high score obtained from the inventory indicates that the need for disease management continues.
    Time Frame
    1. month
    Title
    Post-intervention measurements
    Description
    Morisky drug compliance scale to measure drug compliance: is a self-report scale consisting of four questions. The questions are answered as "yes (1 point) and no (0 point). Increasing the score obtained from the scale indicates that drug compliance is low.
    Time Frame
    1. week
    Title
    Post-intervention measurements
    Description
    The Turkish version of the World Health Organization Quality of Life Inventory Short Form will be used to measure the quality of life. The scale is a Likert type form consisting of 27 questions. Higher total scores obtained from the scale indicate a good quality of life.
    Time Frame
    1. month

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Over the age of 18, Does not have a communication problem that prevents participation in research or education, such as inability to understand / speak Turkish, Being literate, Residing in Zonguldak province, applying to hospitals in the province and diagnosed with Covid-19 according to PCR (Polymerase Chain Reaction) test and Thorax CT (Thorax computed tomography) results by the radiation teams and deemed appropriate for home follow-up by the Zonguldak Public Health Directorate, Having active Internet access and actively using a computer / tablet or smartphone, Patients who agree to participate in the study Exclusion Criteria: No internet connection at home or on the phone, Do not know how to use internet and computers, Having a communication problem that prevents participation in research or education, such as inability to understand / speak Turkish, Patients who were previously diagnosed with Covid-19 and treated at home or in hospital, With severe insufficiency (Heart failure, Kidney failure, Immune system failure) Illiterate individuals will not be included in the study.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Ebru Arslan Özdemir, PhD Student
    Phone
    +90 531 420 96 53
    Email
    ebruaarslan@gmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Özlem Örsal, Prof. Dr.
    Phone
    0 222 239 37 50
    Ext
    1105
    Email
    ozlorsal@yahoo.com

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    The Effects of Web-Based Training for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life

    We'll reach out to this number within 24 hrs